title: [Liver transplantation for hilar cholangiocarcinoma].
abstract: Local non-resectable, hilar cholangiocarcinoma can be cured by performing a liver transplantation. The initially poor results after transplantation have significantly improved since neoadjuvant therapy protocols have been established. Therefore, hilar cholangiocarcinoma is now an accepted indication for liver transplantation in selected patients. This article summarizes the current state, recommendations and results of liver transplantation for these patients.
authors.affiliation: Klinik für Allgemein-, Viszeral- und Gefäßchirurgie, Universitätsklinikum Jena, Erlanger Allee 101, 07747, Jena, Deutschland. Falk.Rauchfuss@med.uni-jena.de
authors.forename: F
authors.initials: F
authors.lastname: Rauchfuss
authors.forename: F
authors.initials: F
authors.lastname: Utess
authors.forename: S
authors.initials: S
authors.lastname: Schüle
authors.forename: Y
authors.initials: Y
authors.lastname: Dittmar
authors.forename: H
authors.initials: H
authors.lastname: Scheuerlein
authors.forename: U
authors.initials: U
authors.lastname: Settmacher
mesh_terms: D001650:Bile Duct Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D003131:Combined Modality Therapy; D006498:Hepatectomy / Q000379:methods; D006500:Hepatic Duct, Common / Q000473:pathology / Q000601:surgery*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D018285:Klatskin Tumor / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D016031:Liver Transplantation / Q000379:methods*; D008197:Lymph Node Excision / Q000379:methods; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D011379:Prognosis; D015996:Survival Rate